Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
44
-
Total shares
-
12.5M
-
Shares change
-
-793K
-
Total reported value, excl. options
-
$24.9M
-
Value change
-
-$4.04M
-
Put/Call ratio
-
0.69
-
Number of buys
-
30
-
Number of sells
-
-35
-
Price
-
$2.00
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2017
46 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2017.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), VANGUARD GROUP INC (1.93M shares), Cormorant Asset Management, LLC (1.69M shares), Intellectus Partners, LLC (1.59M shares), MILLENNIUM MANAGEMENT LLC (694K shares), BlackRock Inc. (503K shares), venBio Select Advisor LLC (416K shares), GEODE CAPITAL MANAGEMENT, LLC (403K shares), GOLDMAN SACHS GROUP INC (272K shares), and DEUTSCHE BANK AG\ (237K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.